Evaluating the Long-term Efficacy of Coronavirus Disease 2019 (COVID-19) Vaccines

Large-scale deployment of safe and durably effective vaccines can curtail the coronavirus disease-2019 (COVID-19) pandemic. However, the high vaccine efficacy (VE) reported by ongoing phase 3 placebo-controlled clinical trials is based on a median follow-up time of only about 2 months, and thus does...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dan-Yu, Zeng, Donglin, Gilbert, Peter B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Invited Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989522/
https://www.ncbi.nlm.nih.gov/pubmed/33693529
http://dx.doi.org/10.1093/cid/ciab226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989522/
https://www.ncbi.nlm.nih.gov/pubmed/33693529
http://dx.doi.org/10.1093/cid/ciab226

Ejemplares similares